Predicting seizure recurrence after status epilepticus: a multicenter exploratory machine learning approach.

Seizure

Epilepsy Unit, Neurology Department, Medicine Department, Universitat Autonoma de Barcelona, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Research Group on Status Epilepticus and Acute Seizures, Vall d'Hebron Research Institute, Vall d'Hebron Universi

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Tools to predict seizure recurrence after status epilepticus (SE) are lacking. In this multicenter cohort study, we explored the ability of different machine learning (ML) models to predict seizure recurrence following a first episode of SE in patients without a prior history of seizures (de novo SE, dnSE).

Methods: Consecutive SE patients aged ≥16 years without a previous history of seizures admitted to Vall d'Hebron University Hospital (Barcelona, Spain) from 2011 to 2021 and Modena Academic Hospital (Baggiovara, Italy) from 2013 to 2022 were reviewed. Different machine learning techniques (k-Nearest Neighbors, Naïve Bayes, Artificial Neural Network, Support Vector Machines, Decision Tree, Random Forest) as well as the classic logistic regression model were built using clinical and neurophysiological variables and applied to develop predictive models of seizure recurrence. Seventy percent of the total sample was randomly selected to train the models; the remaining 30 % was used for validation. The area under the receiver operating characteristic curves (AUROC) with a 95 % confidence interval (95 % CI) was calculated to assess their predictive capability.

Results: A total of 386 patients were included, of which 136 (35.2 %) had seizure recurrence within 2 years after the SE episode. Factors significantly associated with two-year seizure recurrence included progressive symptomatic SE etiology (p < 0.001), non-convulsive SE with coma (p = 0.021), and out-of-hospital SE (p = 0.033). Acute symptomatic SE etiology resulted a protective factor (p < 0.001). Among ML techniques, all were slightly superior to the logistic regression model in predicting two-year seizure recurrence, except for Artificial Neural Network. The Random Forest algorithm (AUROC 0.687, 95 %CI = 0.580 - 0.793) demonstrated the best predictive capability in the validation dataset, significantly outperforming the logistic regression model (AUROC 0.594, 95 %CI = 0.478 - 0.710).

Conclusions: In our study, the Random Forest algorithm showed the best predictive capability for two-year seizure recurrence after a dnSE in adult patients. Further studies and additional data are needed to improve its predictive performance.

Plain Language Summary: This multicenter international retrospective study found that over one-third (35.2 %) of patients who develop status epilepticus without a prior history of epilepsy will have a new seizure within two years after the event. By providing clinical and demographic variables, machine learning algorithms were built and their ability to predict seizure recurrence compared with that of classical statistical model. This is the first study to show that artificial intelligence - specifically, Random Forest algorithm - can outperform traditional statistical methods in predicting seizure recurrence in these patients. However, their performance remains unsatisfactory, requiring further research and additional data to improve predictive accuracy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.seizure.2025.06.019DOI Listing

Publication Analysis

Top Keywords

seizure recurrence
40
machine learning
16
random forest
16
status epilepticus
12
predict seizure
12
logistic regression
12
regression model
12
two-year seizure
12
forest algorithm
12
recurrence
10

Similar Publications

This case study reports the first documented use of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RFTC) to treat refractory status epilepticus (RSE). A 33-year-old woman with drug-resistant epilepsy and recurrent RSE underwent SEEG to define her epileptogenic zone. A new RSE started shortly before and continued during the SEEG exploration, being unresponsive to multiple antiseizure medications, vagal nerve stimulation, and corticosteroid therapy.

View Article and Find Full Text PDF

Congenital disorders of glycosylation (CDG) are a heterogeneous group of inherited metabolic diseases (IMD) characterized by defects in the synthesis and modification of glycoproteins and glycolipids. One of these disorders is ATP6AP1-CDG, a rare X-linked disease with approximately 30 cases reported so far. Symptoms associated with ATP6AP1-CDG include immunodeficiency, liver dysfunction, and neurological manifestations.

View Article and Find Full Text PDF

Although glutamatergic and GABAergic synapses are important in seizure generation, the contribution of non-synaptic ionic and electrical mechanisms to synchronization of seizure-prone hippocampal neurons remains unclear. Here, we developed a physiologically relevant model to study these mechanisms by inducing prolonged seizure-like discharges (SLDs) in hippocampal slices from male rats through modest, sustained ionic manipulations. Specifically, we reduced extracellular calcium to 0.

View Article and Find Full Text PDF

Background: Myxoid spindle cell neoplasm and meningioma are two different pathologies that can have similar radiographic findings. Despite their benign radiographic appearance, myxoid spindle cell neoplasms are heterogeneous, prone to recurrence, and associated with high mortality.

Observations: The authors present the case of a woman in her late 60s who experienced a witnessed seizure characterized by right arm tonic-clonic movements and subsequent left-sided manifestations.

View Article and Find Full Text PDF

Rewiring the seizing brain: stem cell grafts as neuromodulatory architects in epilepsy therapy.

Front Neurol

August 2025

Department of Neurosurgery, Haikou Hospital Affiliated with Xiangya Medical College, Central South University, Haikou, China.

As an emerging therapeutic strategy, stem cell transplantation has demonstrated promising potential in the management of refractory epilepsy. Epilepsy, a prevalent neurological disorder characterized by recurrent seizures, affects approximately one-third of patients worldwide who exhibit resistance to existing antiepileptic drugs (AEDs). Consequently, exploring novel treatment modalities is imperative.

View Article and Find Full Text PDF